General Range
FORAXIME CV
Price on request/100 · MOQ 100 boxes
FORAXIME CV Dry Syrup by Fortune Labs contains Cefixime and Potassium Clavulanate, an antibiotic combination formulated for managing selected bacterial infections. Cefixime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate helps protect it against certain bacterial beta-lactamase enzymes. FORAXIME CV may be prescribed for susceptible respiratory tract, ear, throat, and urinary tract infections when clinically appropriate. Its pediatric oral suspension formulation allows administration according to prescribed instructions. Available in convenient dry syrup packaging with water for reconstitution, this product is part of Fortune Labs' pediatric pharmaceutical portfolio. Contact Fortune Labs for Pediatric PCD Pharma Franchise opportunities, wholesale pricing, product availability, and distribution enquiries across India. Use only under medical supervision.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefixime + Potassium Clavulanate Oral Suspension
- Packaging Type
- Dry Syrup Bottle with Outer Carton and Water for Reconstitution
- Packaging Size
- 30 ml
- Dosage Form
- Oral Suspension
- Treatment
- Selected bacterial respiratory tract infections, throat infections, ear infections, urinary tract infections, and other infections caused by susceptib
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
